52 related articles for article (PubMed ID: 9379333)
1. CD30+ lymphocytes in chronic gingivitis from HIV-positive patients: a pilot study.
Gomez RS; de Souza PE; da Costa JE; Araújo NS
J Periodontol; 1997 Sep; 68(9):881-3. PubMed ID: 9379333
[TBL] [Abstract][Full Text] [Related]
2. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
Pellegrini P; Berghella AM; Contasta I; Adorno D
Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
[TBL] [Abstract][Full Text] [Related]
3. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis.
Ledru E; Lecoeur H; Garcia S; Debord T; Gougeon ML
J Immunol; 1998 Apr; 160(7):3194-206. PubMed ID: 9531275
[TBL] [Abstract][Full Text] [Related]
4. IgG subclass specific antibody response to periodontopathic organisms in HIV-positive patients.
Yeung SC; Taylor BA; Sherson W; Lazarus R; Zhao ZZ; Bird PS; Hamlet SM; Bannon M; Daly C; Seymour GJ
J Periodontol; 2002 Dec; 73(12):1444-50. PubMed ID: 12546094
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of CD30 as a marker for th2 lymphocytes in bronchoalveolar lavage in interstitial lung diseases.
Petkova D; Xaubet A; Picado C; Filella X; Agusti C; Luburich P; Rodriguez-Roisin R
Respir Med; 2000 Apr; 94(4):345-9. PubMed ID: 10845432
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD30 ligand (CD153) on murine activated T cells.
Shimozato O; Takeda K; Yagita H; Okumura K
Biochem Biophys Res Commun; 1999 Mar; 256(3):519-26. PubMed ID: 10080930
[TBL] [Abstract][Full Text] [Related]
7. Alterations in CD30(+) T cells in monoclonal gammopathy of undetermined significance.
Ellis TM; Le PT; DeVries G; Stubbs E; Fisher M; Bhoopalam N
Clin Immunol; 2001 Mar; 98(3):301-7. PubMed ID: 11237552
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1beta, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis.
Orozco A; Gemmell E; Bickel M; Seymour GJ
Oral Microbiol Immunol; 2006 Aug; 21(4):256-60. PubMed ID: 16842511
[TBL] [Abstract][Full Text] [Related]
9. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition.
Chilosi M; Facchetti F; Notarangelo LD; Romagnani S; Del Prete G; Almerigogna F; De Carli M; Pizzolo G
Eur J Immunol; 1996 Feb; 26(2):329-34. PubMed ID: 8617299
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of linear gingival erythema from HIV-positive patients.
Gomez RS; da Costa JE; Loyola AM; de Araújo NS; de Araújo VC
J Periodontal Res; 1995 Sep; 30(5):355-9. PubMed ID: 7494178
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of apical periodontal cysts.
Cury VC; Sette PS; da Silva JV; de Araújo VC; Gomez RS
J Endod; 1998 Jan; 24(1):36-7. PubMed ID: 9487864
[TBL] [Abstract][Full Text] [Related]
12. In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells.
D'Elios MM; Romagnani P; Scaletti C; Annunziato F; Manghetti M; Mavilia C; Parronchi P; Pupilli C; Pizzolo G; Maggi E; Del Prete GF; Romagnani S
J Leukoc Biol; 1997 May; 61(5):539-44. PubMed ID: 9129201
[TBL] [Abstract][Full Text] [Related]
13. Skewing of cytotoxic activity and chemokine production, but not of chemokine receptor expression, in human type-1/-2 gamma delta T lymphocytes.
Dagna L; Iellem A; Biswas P; Resta D; Tantardini F; Fortis C; Sabbadini MG; D'Ambrosio D; Manfredi AA; Ferrarini M
Eur J Immunol; 2002 Oct; 32(10):2934-43. PubMed ID: 12355447
[TBL] [Abstract][Full Text] [Related]
14. Synergistic immunosuppression by candida in HIV infection: a cytokine based analysis.
Bajaj JS; Singh A; Aggarwal SK; Chattopadhya D; Baveja UK
J Commun Dis; 2000 Mar; 32(1):1-9. PubMed ID: 11186879
[TBL] [Abstract][Full Text] [Related]
15. Progressive infection in a subset of HIV-1-positive chimpanzees.
O'Neil SP; Novembre FJ; Hill AB; Suwyn C; Hart CE; Evans-Strickfaden T; Anderson DC; deRosayro J; Herndon JG; Saucier M; McClure HM
J Infect Dis; 2000 Oct; 182(4):1051-62. PubMed ID: 10979899
[TBL] [Abstract][Full Text] [Related]
16. CD30 expression on allergen- and non-allergen-specific T cell lines and its role in cytokine production.
Tarkowski M
Arch Immunol Ther Exp (Warsz); 2003; 51(5):335-43. PubMed ID: 14626433
[TBL] [Abstract][Full Text] [Related]
17. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
[TBL] [Abstract][Full Text] [Related]
18. The association between gingival crevicular fluid TGF-beta1 levels and periodontal status in HIV-1(+) patients.
Alpagot T; Konopka K; Bhattacharyya M; Gebremedhin S; Düzgüneş N
J Periodontol; 2008 Jan; 79(1):123-30. PubMed ID: 18166101
[TBL] [Abstract][Full Text] [Related]
19. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
[TBL] [Abstract][Full Text] [Related]
20. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones.
Piccinni MP; Giudizi MG; Biagiotti R; Beloni L; Giannarini L; Sampognaro S; Parronchi P; Manetti R; Annunziato F; Livi C
J Immunol; 1995 Jul; 155(1):128-33. PubMed ID: 7541410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
